COVID-19 Update:Learn where you can get your child vaccinated, as well as other important facts about COVID-19.
Resources for Providers
Diagnosis and Management of Celiac Disease
Diagnosis of celiac disease is typically twofold – first, elevated levels of tissue transglutaminase IgA (tTG-IgA) are detected by serology. The diagnosis is confirmed upon duodenal mucosal biopsies. For patients demonstrating IgA deficiency, IgG-based testing should be performed (e.x., tTG-IgG). For a full discussion on the details of celiac disease diagnosis, please refer to these guidelines. As a secondary reference, you may review the American College of Gastroenterology (ACG) clinical guidelines.
Our Program History
John D. Synder, M.D. (1947-2016) was the first Medical Director of the Celiac Disease Program at Children’s National Hospital at its inception in 2009. Tragically, he passed away suddenly after sustaining a critical injury during a cycling accident in France. Before his death, he significantly expanded the breadth of services offered by Children’s National. Dr. Snyder also left guidance in a much-needed report on how to manage celiac disease in children. This article is now considered to be the central set of recommendations for follow-up care in pediatric celiac disease.
The Celiac Disease Program at Children’s National Hospital is proud to offer a selection of Continuing Education (CE) and Continuing Medical Education (CME) for providers who care for patients with celiac disease. To access these courses, please choose from the selection below:
- Celiac Disease in Learning Environments: A Training for Healthcare Providers Who Diagnose And Care For Children With Celiac Disease
- Celiac Disease Psychosocial Health Program